In late-session health care news, Bristol Myers Squibb shares are higher after the company won approval from US regulators for its treatment for advanced melanoma. The US Food and Drug Administration gave the thumbs up for patients with widely-spread melanoma, the report said. The drug is meant for patients who haven’t been helped by other treatments. Meanwhile, Johnson & Johnson (JNJ) shares are down in late trading after the health care products maker announced late Thursday after market close that its Ethicon unit has issued a recall of medical drainage products because of sterility concerns. Being recalled are product lots of Blake silicone drains and silicone drain kits, Blake cardio connectors, J-Vac reservoirs and J-Vac drain adapters that were distributed between May 10, 2010 and Feb. 28.